nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Skin reaction—Capecitabine—esophageal cancer	0.199	0.224	CcSEcCtD
Latanoprost—Localised skin reaction—Capecitabine—esophageal cancer	0.199	0.224	CcSEcCtD
Latanoprost—Iloprost—PDE4D—esophageal cancer	0.0514	0.767	CrCbGaD
Latanoprost—Scab—Capecitabine—esophageal cancer	0.0378	0.0424	CcSEcCtD
Latanoprost—Embolism—Capecitabine—esophageal cancer	0.0187	0.021	CcSEcCtD
Latanoprost—Keratitis—Capecitabine—esophageal cancer	0.0185	0.0208	CcSEcCtD
Latanoprost—Pain—Carboplatin—esophageal cancer	0.0169	0.019	CcSEcCtD
Latanoprost—Tafluprost—PTGS2—esophageal cancer	0.0156	0.233	CrCbGaD
Latanoprost—Eye irritation—Capecitabine—esophageal cancer	0.0141	0.0158	CcSEcCtD
Latanoprost—Embolism—Methotrexate—esophageal cancer	0.0139	0.0156	CcSEcCtD
Latanoprost—Lacrimation increased—Capecitabine—esophageal cancer	0.013	0.0146	CcSEcCtD
Latanoprost—Inflammation—Capecitabine—esophageal cancer	0.0124	0.0139	CcSEcCtD
Latanoprost—Dry eye—Capecitabine—esophageal cancer	0.0111	0.0125	CcSEcCtD
Latanoprost—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00997	0.0112	CcSEcCtD
Latanoprost—Eye pain—Capecitabine—esophageal cancer	0.00965	0.0108	CcSEcCtD
Latanoprost—Inflammation—Methotrexate—esophageal cancer	0.00921	0.0104	CcSEcCtD
Latanoprost—Conjunctivitis—Cisplatin—esophageal cancer	0.00886	0.00995	CcSEcCtD
Latanoprost—Diplopia—Capecitabine—esophageal cancer	0.00872	0.00979	CcSEcCtD
Latanoprost—Connective tissue disorder—Cisplatin—esophageal cancer	0.00804	0.00903	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00785	0.00882	CcSEcCtD
Latanoprost—Asthma—Capecitabine—esophageal cancer	0.00753	0.00846	CcSEcCtD
Latanoprost—Mediastinal disorder—Cisplatin—esophageal cancer	0.00737	0.00828	CcSEcCtD
Latanoprost—Angina pectoris—Capecitabine—esophageal cancer	0.00734	0.00824	CcSEcCtD
Latanoprost—Bronchitis—Capecitabine—esophageal cancer	0.00724	0.00814	CcSEcCtD
Latanoprost—Erythema—Cisplatin—esophageal cancer	0.00712	0.008	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.007	0.00786	CcSEcCtD
Latanoprost—Vision blurred—Cisplatin—esophageal cancer	0.00671	0.00754	CcSEcCtD
Latanoprost—Conjunctivitis—Capecitabine—esophageal cancer	0.00653	0.00733	CcSEcCtD
Latanoprost—Urinary tract infection—Capecitabine—esophageal cancer	0.00653	0.00733	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00602	0.00676	CcSEcCtD
Latanoprost—Discomfort—Cisplatin—esophageal cancer	0.00599	0.00673	CcSEcCtD
Latanoprost—Connective tissue disorder—Capecitabine—esophageal cancer	0.00593	0.00666	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00584	0.00656	CcSEcCtD
Latanoprost—Oedema—Cisplatin—esophageal cancer	0.00581	0.00653	CcSEcCtD
Latanoprost—Nervous system disorder—Cisplatin—esophageal cancer	0.0057	0.0064	CcSEcCtD
Latanoprost—Skin disorder—Cisplatin—esophageal cancer	0.00564	0.00634	CcSEcCtD
Latanoprost—Asthma—Methotrexate—esophageal cancer	0.00561	0.0063	CcSEcCtD
Latanoprost—Mediastinal disorder—Capecitabine—esophageal cancer	0.00543	0.0061	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00529	0.00595	CcSEcCtD
Latanoprost—Erythema—Capecitabine—esophageal cancer	0.00525	0.0059	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00521	0.00585	CcSEcCtD
Latanoprost—Dyspnoea—Cisplatin—esophageal cancer	0.00518	0.00582	CcSEcCtD
Latanoprost—Back pain—Capecitabine—esophageal cancer	0.00508	0.0057	CcSEcCtD
Latanoprost—Pain—Cisplatin—esophageal cancer	0.00497	0.00558	CcSEcCtD
Latanoprost—Vision blurred—Capecitabine—esophageal cancer	0.00495	0.00556	CcSEcCtD
Latanoprost—Conjunctivitis—Methotrexate—esophageal cancer	0.00486	0.00546	CcSEcCtD
Latanoprost—Arthralgia—Capecitabine—esophageal cancer	0.00447	0.00502	CcSEcCtD
Latanoprost—Chest pain—Capecitabine—esophageal cancer	0.00447	0.00502	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00444	0.00498	CcSEcCtD
Latanoprost—Discomfort—Capecitabine—esophageal cancer	0.00442	0.00496	CcSEcCtD
Latanoprost—Oedema—Capecitabine—esophageal cancer	0.00428	0.00481	CcSEcCtD
Latanoprost—Nervous system disorder—Capecitabine—esophageal cancer	0.0042	0.00472	CcSEcCtD
Latanoprost—Skin disorder—Capecitabine—esophageal cancer	0.00416	0.00467	CcSEcCtD
Latanoprost—Mediastinal disorder—Methotrexate—esophageal cancer	0.00405	0.00454	CcSEcCtD
Latanoprost—Erythema—Methotrexate—esophageal cancer	0.00391	0.00439	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0039	0.00438	CcSEcCtD
Latanoprost—Dyspnoea—Capecitabine—esophageal cancer	0.00382	0.00429	CcSEcCtD
Latanoprost—Back pain—Methotrexate—esophageal cancer	0.00378	0.00425	CcSEcCtD
Latanoprost—Vision blurred—Methotrexate—esophageal cancer	0.00368	0.00414	CcSEcCtD
Latanoprost—Rash—Cisplatin—esophageal cancer	0.00366	0.00412	CcSEcCtD
Latanoprost—Pain—Capecitabine—esophageal cancer	0.00366	0.00411	CcSEcCtD
Latanoprost—Dermatitis—Cisplatin—esophageal cancer	0.00366	0.00411	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.00354	0.0828	CbGpPWpGaD
Latanoprost—Arthralgia—Methotrexate—esophageal cancer	0.00333	0.00374	CcSEcCtD
Latanoprost—Chest pain—Methotrexate—esophageal cancer	0.00333	0.00374	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.0033	0.00371	CcSEcCtD
Latanoprost—Discomfort—Methotrexate—esophageal cancer	0.00329	0.00369	CcSEcCtD
Latanoprost—SLC22A1—Abacavir transmembrane transport—ABCB1—esophageal cancer	0.00322	0.0753	CbGpPWpGaD
Latanoprost—Nervous system disorder—Methotrexate—esophageal cancer	0.00313	0.00351	CcSEcCtD
Latanoprost—Skin disorder—Methotrexate—esophageal cancer	0.0031	0.00348	CcSEcCtD
Latanoprost—Pruritus—Capecitabine—esophageal cancer	0.00303	0.0034	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00291	0.00326	CcSEcCtD
Latanoprost—Dyspnoea—Methotrexate—esophageal cancer	0.00284	0.00319	CcSEcCtD
Latanoprost—Dizziness—Capecitabine—esophageal cancer	0.00283	0.00318	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.00278	0.065	CbGpPWpGaD
Latanoprost—Pain—Methotrexate—esophageal cancer	0.00273	0.00306	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.00272	0.0637	CbGpPWpGaD
Latanoprost—Rash—Capecitabine—esophageal cancer	0.0027	0.00303	CcSEcCtD
Latanoprost—Dermatitis—Capecitabine—esophageal cancer	0.0027	0.00303	CcSEcCtD
Latanoprost—Headache—Capecitabine—esophageal cancer	0.00268	0.00301	CcSEcCtD
Latanoprost—Pruritus—Methotrexate—esophageal cancer	0.00226	0.00253	CcSEcCtD
Latanoprost—Dizziness—Methotrexate—esophageal cancer	0.00211	0.00237	CcSEcCtD
Latanoprost—Rash—Methotrexate—esophageal cancer	0.00201	0.00226	CcSEcCtD
Latanoprost—Dermatitis—Methotrexate—esophageal cancer	0.00201	0.00226	CcSEcCtD
Latanoprost—Headache—Methotrexate—esophageal cancer	0.002	0.00224	CcSEcCtD
Latanoprost—SLC22A1—Abacavir transport and metabolism—ABCB1—esophageal cancer	0.00185	0.0432	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.00106	0.0249	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000828	0.0194	CbGpPWpGaD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000816	0.0191	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—GNG7—esophageal cancer	0.000769	0.018	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000757	0.0177	CbGpPWpGaD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000746	0.0175	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—ADCYAP1—esophageal cancer	0.000692	0.0162	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNG7—esophageal cancer	0.000688	0.0161	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—ANXA1—esophageal cancer	0.00063	0.0147	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—GHRL—esophageal cancer	0.000597	0.014	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—esophageal cancer	0.000564	0.0132	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—esophageal cancer	0.000534	0.0125	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000472	0.011	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.000449	0.0105	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000444	0.0104	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000421	0.00984	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.000417	0.00976	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.000406	0.0095	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000401	0.00939	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.000396	0.00926	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000391	0.00915	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—GNG7—esophageal cancer	0.000388	0.00908	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000385	0.009	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000385	0.009	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000371	0.00868	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADCYAP1—esophageal cancer	0.000355	0.00831	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL2—esophageal cancer	0.000342	0.008	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000339	0.00794	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GDI2—esophageal cancer	0.000326	0.00762	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—ANXA1—esophageal cancer	0.000318	0.00743	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—SST—esophageal cancer	0.000309	0.00723	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—GHRL—esophageal cancer	0.000301	0.00705	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000291	0.00682	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000288	0.00673	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00027	0.00631	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000264	0.00619	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKAP13—esophageal cancer	0.000252	0.0059	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KMT2D—esophageal cancer	0.000235	0.00551	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PDE4D—esophageal cancer	0.00023	0.00539	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKAP13—esophageal cancer	0.000229	0.00535	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—GNG7—esophageal cancer	0.00022	0.00516	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GNG7—esophageal cancer	0.000219	0.00513	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000211	0.00495	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADCYAP1—esophageal cancer	0.00021	0.00491	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PDE4D—esophageal cancer	0.000209	0.0049	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—ALDH2—esophageal cancer	0.000207	0.00483	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GNG7—esophageal cancer	0.000199	0.00466	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000199	0.00465	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL2—esophageal cancer	0.000193	0.00452	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—WWOX—esophageal cancer	0.000192	0.00449	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000188	0.00441	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FKBP1A—esophageal cancer	0.000183	0.00427	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00018	0.00421	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ANXA1—esophageal cancer	0.00018	0.0042	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—WIF1—esophageal cancer	0.000178	0.00417	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL2—esophageal cancer	0.000175	0.0041	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—SST—esophageal cancer	0.000175	0.00409	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000172	0.00403	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000172	0.00403	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GHRL—esophageal cancer	0.00017	0.00398	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CSNK1A1—esophageal cancer	0.000165	0.00385	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ANXA1—esophageal cancer	0.000163	0.00382	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000161	0.00377	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—SST—esophageal cancer	0.000159	0.00371	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000156	0.00365	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000155	0.00362	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GHRL—esophageal cancer	0.000155	0.00362	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PFN1—esophageal cancer	0.000154	0.0036	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000151	0.00354	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ELMO1—esophageal cancer	0.000138	0.00324	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000135	0.00317	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKAP13—esophageal cancer	0.000135	0.00316	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000131	0.00306	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000125	0.00292	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDE4D—esophageal cancer	0.000124	0.00289	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000119	0.00277	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GNG7—esophageal cancer	0.000118	0.00275	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC52A3—esophageal cancer	0.000116	0.00272	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BLVRB—esophageal cancer	0.000116	0.00272	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—XIAP—esophageal cancer	0.00011	0.00258	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CTNNA1—esophageal cancer	0.000104	0.00244	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL2—esophageal cancer	0.000104	0.00242	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000103	0.00242	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC10A2—esophageal cancer	9.9e-05	0.00232	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA1—esophageal cancer	9.9e-05	0.00232	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PSME1—esophageal cancer	9.68e-05	0.00226	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PSME2—esophageal cancer	9.68e-05	0.00226	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ANXA1—esophageal cancer	9.63e-05	0.00225	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SST—esophageal cancer	9.37e-05	0.00219	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GHRL—esophageal cancer	9.13e-05	0.00214	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH3—esophageal cancer	9.13e-05	0.00214	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA2—esophageal cancer	9.06e-05	0.00212	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FBXW7—esophageal cancer	8.98e-05	0.0021	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADH7—esophageal cancer	8.42e-05	0.00197	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLCE1—esophageal cancer	8.42e-05	0.00197	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH2—esophageal cancer	8.19e-05	0.00192	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADH1B—esophageal cancer	7.38e-05	0.00173	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFBR2—esophageal cancer	7.27e-05	0.0017	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.22e-05	0.00169	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TYMP—esophageal cancer	7.06e-05	0.00165	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.93e-05	0.00162	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SMAD4—esophageal cancer	6.88e-05	0.00161	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP26A1—esophageal cancer	6.86e-05	0.00161	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALOX15—esophageal cancer	6.69e-05	0.00157	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTO1—esophageal cancer	6.38e-05	0.00149	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TPI1—esophageal cancer	6.38e-05	0.00149	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDOB—esophageal cancer	6.12e-05	0.00143	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GAPDH—esophageal cancer	5.89e-05	0.00138	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CRABP1—esophageal cancer	5.84e-05	0.00137	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIF1A—esophageal cancer	5.63e-05	0.00132	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GNG7—esophageal cancer	5.55e-05	0.0013	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KDR—esophageal cancer	5.38e-05	0.00126	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDH2—esophageal cancer	5.2e-05	0.00122	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH1—esophageal cancer	5.07e-05	0.00119	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—esophageal cancer	4.95e-05	0.00116	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2A6—esophageal cancer	4.89e-05	0.00114	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS1—esophageal cancer	4.64e-05	0.00108	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENO1—esophageal cancer	4.64e-05	0.00108	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.63e-05	0.00108	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CREBBP—esophageal cancer	4.6e-05	0.00108	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PSME2—esophageal cancer	4.57e-05	0.00107	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PSME1—esophageal cancer	4.57e-05	0.00107	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—esophageal cancer	4.52e-05	0.00106	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—esophageal cancer	4.32e-05	0.00101	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—esophageal cancer	4.12e-05	0.000963	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1B1—esophageal cancer	3.94e-05	0.000922	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—esophageal cancer	3.92e-05	0.000917	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB2—esophageal cancer	3.85e-05	0.000901	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP19A1—esophageal cancer	3.71e-05	0.000867	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCND1—esophageal cancer	3.4e-05	0.000796	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—esophageal cancer	3.38e-05	0.000791	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1A—esophageal cancer	3.29e-05	0.00077	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCB1—esophageal cancer	3.25e-05	0.00076	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EP300—esophageal cancer	3.13e-05	0.000733	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—esophageal cancer	2.73e-05	0.000638	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—esophageal cancer	2.67e-05	0.000624	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—esophageal cancer	2.32e-05	0.000542	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—esophageal cancer	2.24e-05	0.000524	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CREBBP—esophageal cancer	2.17e-05	0.000508	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—esophageal cancer	1.94e-05	0.000455	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—esophageal cancer	1.78e-05	0.000416	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—EP300—esophageal cancer	1.48e-05	0.000346	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1.09e-05	0.000256	CbGpPWpGaD
